Should I Buy RKLB? RKLB 2026 Analysis

Should You Buy Rocket Lab Corp (RKLB) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Buy

Latest Price

85.680

1 Day change

-3.26%

52 Week Range

99.580

Analysis Updated At

2026/01/26

Rocket Lab Corp (RKLB) is a good buy for a beginner investor with a long-term horizon and $50,000-$100,000 available for investment. Despite short-term challenges such as the Neutron Stage 1 tank rupture and potential delays, the company's strong growth trajectory, increasing revenue, and significant defense contracts position it well for long-term success. Additionally, hedge fund buying activity and positive analyst sentiment further support the investment case.

Technical Analysis

The technical indicators show mixed signals. While the MACD is negative and expanding downward, indicating bearish momentum, the RSI is neutral at 56.369. The moving averages are bullish (SMA_5 > SMA_20 > SMA_200), suggesting an overall upward trend. The stock is trading near a support level of 83.082, which could provide a solid entry point for long-term investors.

Options Data

Bullish

Open Interest Put-Call Ratio

Bearish

Option Volume Put-Call Ratio

The options market shows a higher put volume compared to call volume, with a Put-Call Ratio of 1.39, indicating bearish sentiment in the short term. However, the open interest Put-Call Ratio of 0.66 suggests a more balanced longer-term outlook.

Technical Summary

Sell

Buy

Positive Catalysts

Hedge funds are aggressively buying, with a 9284.72% increase in buying activity over the last quarter.
Analysts have raised price targets significantly, with BofA setting a target of $120 and Morgan Stanley upgrading the stock to Overweight.
The company secured its largest-ever defense contract worth $805M, validating its position as a key player in the space industry.
Revenue growth of 47.97% YoY in Q3 2025, driven by strong performance in both Space Systems and Launch segments.

Neutral/Negative Catalysts

Insiders are selling heavily, with a 2217.13% increase in selling activity over the last month.
The Neutron Stage 1 tank rupture may delay the initial launch, potentially impacting investor sentiment.
Net income dropped by -64.85% YoY, and EPS fell by -70.00% YoY, indicating profitability challenges.

Financial Performance

In Q3 2025, Rocket Lab reported revenue growth of 47.97% YoY to $155.08M, driven by strong performance in both Space Systems (up 36%) and Launch (up 95%) segments. Gross margin improved significantly to 36.96%, up 38.38% YoY. However, net income dropped to -$18.26M (-64.85% YoY), and EPS declined to -$0.03 (-70.00% YoY), reflecting ongoing profitability challenges.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment is broadly positive, with multiple firms maintaining Buy ratings and raising price targets. BofA set a target of $120, citing vertical integration and defense contracts as key growth drivers. Morgan Stanley upgraded the stock to Overweight with a $105 target, highlighting favorable industry trends. However, some analysts note risks related to Neutron launch delays and profitability challenges.

11 Analyst Rating

Wall Street analysts forecast RKLB stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for RKLB is 73.11 USD with a low forecast of 60 USD and a high forecast of 90 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

8 Buy

3 Hold

0 Sell

Moderate Buy

Current: 88.570

Low

Averages

73.11

High

Current: 88.570

Low

Averages

73.11

High

TD Cowen

Buy

maintain

$100

AI Analysis

2026-01-22

Reason

TD Cowen

Price Target

$100

AI Analysis

2026-01-22

maintain

Buy

Reason

TD Cowen keeps a Buy rating on Rocket Lab with a $100 price target after the company confirmed Neutron's Stage 1 tank ruptured under pressure tests. The company indicated there was no significant damage to the test structure or facilities and that the next Stage 1 tank is already in production, the analyst tells investors in a research note. However, the rupture may delay Neutron's initial launch, which was set to occur in Q2. If a launch delay results from the tank rupture, a second Neutron launch in 2026 would be unlikely, adds TD. Rocket Lab shares are down 1% to $86.52 in premarket trading.

Goldman Sachs

Anthony Valentini

Neutral

maintain

$47 -> $69

2026-01-20

Reason

Goldman Sachs

Anthony Valentini

Price Target

$47 -> $69

2026-01-20

maintain

Neutral

Reason

Goldman Sachs analyst Anthony Valentini raised the firm's price target on Rocket Lab to $69 from $47 and keeps a Neutral rating on the shares. The firm's Q4 Aerospace & Defense preview highlights favorable aerospace OE conditions, with supply below demand, while aftermarket growth outpaces global ASMs with strong pricing supporting margins, the analyst tells investors in a research note. Business jet demand remains solid amid tight supply, defense hardware growth is improving though margins face risk from shifting contracts, defense tech momentum emphasizes faster, commercial-style providers, and federal IT obligations continue under pressure, the firm says.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for RKLB

Unlock Now

RKLB Should I Buy

RKLB Should I Buy

Should You Buy Rocket Lab Corp (RKLB) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch